Douglas C. Lane & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $19.9M | Sell |
684,784
-32,322
| -5% | -$939K | 0.54% | 69 |
|
|
2015
Q3 | $19.4M | Sell |
717,106
-1,898
| -0.3% | -$51.5K | 0.55% | 69 |
|
|
2015
Q2 | $19.7M | Sell |
719,004
-21,838
| -3% | -$598K | 0.53% | 71 |
|
|
2015
Q1 | $19.8M | Buy |
740,842
+112,470
| +18% | +$3M | 0.52% | 72 |
|
|
2014
Q4 | $13.3M | Buy |
628,372
+146,386
| +30% | +$3.1M | 0.36% | 92 |
|
|
2014
Q3 | $11.5M | Buy |
481,986
+140,744
| +41% | +$3.35M | 0.34% | 92 |
|
|
2014
Q2 | $7.88M | Buy |
341,242
+180,932
| +113% | +$4.18M | 0.24% | 101 |
|
|
2014
Q1 | $3.66M | Buy |
+160,310
| New | +$3.66M | 0.12% | 116 |
|